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Abstract
Objectives: Binge alcohol drinking often triggers myocardial contractile dysfunction although the underlying mechanism is
not fully clear. This study was designed to examine the impact of cardiac-specific overexpression of alcohol dehydrogenase
(ADH) on ethanol-induced change in cardiac contractile function, intracellular Ca
2+ homeostasis, insulin and AMP-
dependent kinase (AMPK) signaling.
Methods: ADH transgenic and wild-type FVB mice were acutely challenged with ethanol (3 g/kg/d, i.p.) for 3 days. Oral
glucose tolerance test, cardiac AMP/ATP levels, cardiac contractile function, intracellular Ca
2+ handling and AMPK signaling
(including ACC and LKB1) were examined.
Results: Ethanol exposure led to glucose intolerance, elevated plasma insulin, compromised cardiac contractile and
intracellular Ca
2+ properties, downregulated protein phosphatase PP2A subunit and PPAR-c, as well as phosphorylation of
AMPK, ACC and LKB1, all of which except plasma insulin were overtly accentuated by ADH transgene. Interestingly,
myocardium from ethanol-treated FVB mice displayed enhanced expression of PP2Ca and PGC-1a, decreased insulin
receptor expression as well as unchanged expression of Glut4, the response of which was unaffected by ADH. Cardiac AMP-
to-ATP ratio was significantly enhanced by ethanol exposure with a more pronounced increase in ADH mice. In addition, the
AMPK inhibitor compound C (10 mM) abrogated acute ethanol exposure-elicited cardiomyocyte mechanical dysfunction.
Conclusions: In summary, these data suggest that the ADH transgene exacerbated acute ethanol toxicity-induced
myocardial contractile dysfunction, intracellular Ca
2+ mishandling and glucose intolerance, indicating a role of ADH in acute
ethanol toxicity-induced cardiac dysfunction possibly related to altered cellular fuel AMPK signaling cascade.
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Introduction
Episodic excessive alcohol consumption or binge drinking is a
devastating public health problem associated with not only somatic
complications but also traffic accidents, violent behavior and
suicide [1]. Binge drinking-associated acute alcohol (ethanol)
toxicity is often accompanied with a variety of risks including
compromised myocardial contractile function [1,2]. Although a
number of theories have been put forward regarding the onset and
progression of ethanol toxicity-induced myopathic changes
including toxicity of ethanol and its metabolites, oxidative stress
and accumulation of fatty acid ethyl esters [3,4], the precise
mechanism(s) of action behind alcohol-elicited cardiac damage
remains controversial. Data from our lab have suggested that
acetaldehyde, the primary metabolic product of ethanol, may
contribute to the ethanol-induced cardiac damage by compromis-
ing myocardial excitation-contraction coupling, sarco(endo)plas-
mic reticulum (SR) Ca
2+ release and cardiac contractile function
[5,6,7]. This notion received further support from our recent
observations of lessened cardiac morphological and functional
damage with the facilitated clearance of acetaldehyde via
mitochondrial aldehyde dehydrogenase (ALDH-2) following acute
or chronic ethanol exposure [8,9]. More interestingly, evidence
also depicted a role of energy metabolism in the ethanol-elicited
tissue and cell damage as ethanol ingestion has been shown to
reduce the level or activity of ATP, cytochrome oxidase, succinate
dehydrogenase and NADH dehydrogenase as well as decrease
mitochondrial respiratory rate and phosphorylation efficiency in a
variety of tissues such as heart, brain and stomach [10,11,12]. This
is somewhat coordinated with our earlier finding that alcohol
dehydrogenase (ADH), which oxidizes ethanol into acetaldehyde,
exacerbated mitochondrial dysfunction manifested as loss of
mitochondrial membrane potential and accumulation of mito-
chondrial O2
2 anion [13]. Given that cardiac energy metabolism
is shown to be altered in response to ethanol intake [14] which
may play a key role in alcoholism-elicited cardiac contractile
function, our present study was designed to address the role of
cellular fuel AMP-activated protein kinase (AMPK) cascade in
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hereby took advantage of a transgenic mouse model with
the cardiac-specific overexpression of ADH, which mimics an
accelerated alcoholic cardiomyopathy model of alcoholic cardio-
myopathy [15]. Cardiac contractile function, intracellular Ca
2+
handling, cardiac AMP/ATP ratio, the main up- and down-
stream signaling molecules of AMPK including LKB1 and acetyl-
CoA carboxylase (ACC) were examined. Expression of proteins
closely associated with energy metabolism and insulin signaling
including PPARc, PGC-1a, insulin receptor b and Glut4 was
examined in wild-type FVB and ADH hearts following acute
ethanol challenge. To monitor the change in the AMPK
degrading phosphatase, expression of protein phosphatase 2A
(PP2A) and protein phosphatase 2Ca (PP2Ca) was examined.
Oral glucose tolerance test and plasma insulin levels were
measured for the overall assessment of glucose handling capacity.
Materials and Methods
Experimental animals and acute ethanol exposure
All animal procedures described here were in accordance with
humane animal care standards outlined in the NIH Guide for the
Care and Use of Experimental and were approved the University
of Wyoming Animal Care and Use Committee (#A-3216-01).
Production of the ADH transgenic mice was described in detail
previously [16]. In brief, using the albino Friend Virus-B type
(FVB) mice, the cDNA for murine class I ADH was inserted
behind mouse a-myosin heavy chain promoter to achieve cardiac-
specific overexpression. This cDNA was chosen because class I
ADH is the most efficient in the oxidation of ethanol. A second
transgene with a cDNA encoding tyrosinase was co-injected with
ADH. This enzyme produces coat color pigmentation in albino
mice and was used to conveniently identify transgenic animals. All
mice were housed in a temperature-controlled room under a
12 hr/12 hr-light/dark and allowed access to tap water ad libitum.
For acute ethanol challenge, adult male FVB and ADH mice (5–7
month-old) were injected intraperitoneally with ethanol (3 g/kg/d)
for 3 consecutive days [13] prior to euthanasia under anesthesia
(ketamine/xylazine: 3:1, 1.32 mg/kg, i.p.) 72 hrs after the initial
ethanol injection. Six hours after ethanol or saline challenge,
blood samples were taken from the tail vein and immediately
deproteinized with 6.25% trichloroacetic acid solution. Plasma
insulin levels were measured using an ELISA commercial kit.
Oral glucose tolerance test (OGTT)
Following a 12-hr overnight fasting period, FVB and ADH mice
with or without acute ethanol challenge were gavaged with glucose
(2 g/kg b.w.). Blood samples were drawn from the tail vein
immediately before the glucose challenge, as well as 15, 30, 60, 90
and 120 min thereafter. Serum glucose levels were determined
using an Accu-Chek III glucose analyzer. The area under the
curve (AUC) was calculated using trapezoidal analysis for each
adjacent time point and serum glucose level [17].
Assessment of ethanol level
Upon sacrifice under anesthesia (ketamine/xylazine: 3:1,
1.32 mg/kg, i.p.), plasma was collected and was stored in sealed
vials at 280uC. Immediately before analysis, samples were
warmed to 25uC. A 2 ml aliquot of the headspace gas from each
vial was removed through the septum on the cap with a gas tight
syringe and transferred to a 200 ml loop injection system on a
Hewlett-Packard 5890 gas chromatograph (GC) equipped with a
flame ionization detector. Ethanol was separated on a 9-meter
VOCOL capillary column (Supelco) with film with 1.8 mm
thickness and an inner diameter of 0.32 mm. The temperature
was held isothermally at 30uC, and the carrier gas was helium at a
flow rate of 1.8 ml/min. Quantitation was achieved by calibrating
the GC peak areas against those from headspace samples of known
ethanol standards, over a similar concentration range as the tissue
samples in the same buffer [16].
HPLC assay of AMP/ATP content
The heart tissues were extracted by 6% perchloric acid (Sigma,
St. Louis, MO). The acidic homogenate was kept on ice for
30 min, and then centrifuged at 14,000 rpm at 4uC for 10 min.
An aliquot of the pellets was set aside for protein measurements.
The supernatant was neutralized with 1 mol/l K2CO3, adjust pH
to 3.5. Then kept the supernatant on ice for 10 min and at 280uC
for 1–2 h to promote precipitation of the perchlorate and
centrifuged again. Supernatants were stored at 280uC until
HPLC assay. The chromatographic separation of AMP was
performed using a Grace Partisil SAX column (250 mm 64m m
i.d., particle size 10 mm) (Deerfield, IL). The mobile phases were
composed of a gradient of 5 mM ammonium dihydrogen
phosphate (pH 2.8) and 750 mM ammonium dihydrogen phos-
phate (pH 3.9). The flow rate was varied from1–2 ml/min over
the course of the gradient profile to provide a reasonable assay
time of 25 min. The sample injection volume was 50 ml and the
components were monitored at 254 nm. The Beckman GOLD
HPLC system was operated in laboratory at room temperature
(23–25uC). Concentrations were determined by construction of a
calibration curve range from 1 to 80 nmoles per 50 ml injected.
Standard stock solutions for calibration curve construction were
6.4 mmole/ml AMP and ATP prepared in 5 mmol/l ammonium
dihydrogen phosphate (pH 2.8). These solutions were stored at
280uC and used as references for peaks quantification. Fresh
dilution was made before each assay to construct a calibration
curve, adding 5 mmol/l ammonium dihydrogen phosphate
(pH 2.8) in order to obtain 1, 5, 10, 20, 40 and 80 nmoles per
50 m l injected [18].
Isolation of murine cardiomyocytes
After ketamine/xylazine sedation, hearts were removed and
perfused with Krebs-Henseleit bicarbonate (KHB) buffer contain-
ing (in mM): 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4,2 5
NaHCO3, 10 HEPES and 11.1 glucose. Hearts were digested with
collagenase D for 20 min. Left ventricles were removed and
minced before being filtered. Myocyte yield was 50%–70% which
was not overtly affected by ADH or ethanol challenge [13]. To
directly assess the role of AMPK in acute ethanol exposure-
induced cardiomyocyte contractile response, cardiomyocytes from
adult wild-type FVB mice were treated with ethanol (240 mg/dl)
at 37uC for 2 hrs in the absence or presence of the AMPK
inhibitor compound C (10 mM) [19] before mechanical function
was assessed.
Cell shortening/relengthening
Mechanical properties of cardiomyocytes were assessed using a
SoftEdge MyoCam system (IonOptix Corporation, Milton, MA)
[18]. In brief, cardiomyocytes were placed in a chamber mounted
on the stage of an inverted microscope (Olympus, IX-70) and
superfused at 25uC with a buffer containing (in mM): 131 NaCl, 4
KCl, 1 CaCl2, 1 MgCl2, 10 Glucose and 10 HEPES, at pH 7.4.
The cells were field stimulated with suprathreshold voltage at a
frequency of 0.5 Hz, 3 msec duration, using a pair of platinum
wires placed on opposite sides of the chamber and connected to an
electrical stimulator (FHC Inc, Brunswick, NE). The myocyte
being studied was displayed on a computer monitor using an
ADH, Ethanol and AMPK
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used to capture changes in cell length during shortening and
relengthening. Cell shortening and relengthening were assessed
using the following indices: peak shortening (PS), maximal
velocities of cell shortening and relengthening (6 dL/dt), time-
to-PS (TPS), and time-to-90% relengthening (TR90). In the case of
altering stimulus frequency from 0.1 to 5.0 Hz, the steady state
contraction of myocyte was achieved (usually after the first 5–6
beats) before PS was recorded.
Intracellular Ca
2+ fluorescence measurement
Myocytes were loaded with fura-2/AM (0.5 mM) for 10 min
and fluorescence measurements were recorded with a dual-
excitation fluorescence photo multiplier system (Ionoptix). Car-
diomyocytes were placed on an Olympus IX-70 inverted
microscope and imaged through a Fluor 406oil objective. Cells
were exposed to light emitted by a 75 W lamp and passed through
either a 360 or a 380 nm filter, while being stimulated to contract
at 0.5 Hz. Fluorescence emissions were detected between 480 and
520 nm by a photomultiplier tube after first illuminating the cells
at 360 nm for 0.5 s then at 380 nm for the duration of the
recording protocol (333 Hz sampling rate). The 360 nm excitation
scan was repeated at the end of the protocol and qualitative
changes in intracellular Ca
2+ concentration were inferred from the
ratio of fura-2 fluorescence intensity at two wavelengths (360/380).
Fluorescence decay time was assessed as an indication of
intracellular Ca
2+ clearing. Both single and bi-exponential curve
fits were applied to calculate the intracellular Ca
2+ decay constant
[18].
Mouse heart perfusion
Isolated mouse hearts were retrogradely perfused with a
Krebs-Henseleit buffer containing 7 mM glucose, 0.4 mM
oleate, 1% BSA and a low fasting concentration of insulin
(10 mU/ml). Hearts were perfused at a constant flow of 4 ml/
min (equal to an aortic pressure of 80 cmH2O) at baseline for
30 min to reach the steady-state. A fluid-filled latex balloon
connected to a solid-state pressure transducer was inserted into
the left ventricle through a left atriotomy to measure left
ventricular pressure between 30 and 90 min after initiation of
perfusion. LVDP and the first derivative of LVDP (6 dP/dt)
were recorded using a digital acquisition system at a balloon
volume which resulted in a baseline LV end-diastolic pressure of
5 mmHg [13].
Table 1. Biometric and myocardial contractile parameters of FVB and ADH mice challenged with ethanol (3 g/kg, i.p. for 3 days).
Parameter FVB FVB-EtOH ADH ADH-EtOH
Body Weight (g) 26.660.6 26.660.9 27.060.6 27.060.7
Heart Weight (mg) 141651 3 1 661 5 2 681 3 7 69
Heart/Body Weight (mg/g) 5.3260.21 4.9660.29 5.6060.24 5.0860.31
Liver Weight (g) 1.2260.07 1.3360.06 1.2760.04 1.3360.06
Liver/Body Weight (mg/g) 46.262.7 49.961.7 47.161.3 49.262.4
Kidney Weight (g) 0.3260.02 0.3360.02 0.3160.01 0.3660.02
Kidney/Body Weight (mg/g) 12.160.6 12.260.6 11.560.5 13.560.6
Cardiac AMP (nmol/mg protein) 7.6460.27 24.3566.72* 8.0760.46 27.1466.56*
Cardiac ATP (nmol/mg protein) 6.7960.11 7.4260.26 6.3760.5 5.0661.31
Cardiac AMP/ATP Ratio 1.1360.04 3.3660.84* 1.3660.16 5.2760.20*
,#
Plasma Insulin (ng/ml) 0.4360.07 1.2560.14* 0.4960.07 1.2960.17*
Blood Alcohol (mg/dl) Undetectable 57.769.3* Undetectable 75.2619.5*
Mean 6 SEM, n=9–10 mice per group, undetectable: ,2.5 mg/dl, * p,0.05 vs. FVB group,
#p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.t001
Figure 1. Oral glucose tolerance test (OGTT, 2 g/kg) in adult
FVB and ADH mice with or without acute ethanol (EtOH)
challenge (3 g/kg, i.p. for 3 days). A: Serum glucose levels within
120 min following acute glucose challenge; B: Area underneath the
curve (AUC). Mean 6 SEM, n=7–9 mice per group, * p,0.05 vs. FVB
group, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g001
ADH, Ethanol and AMPK
PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e11268Western blot analysis
Myocardial protein from the left ventricles was prepared as
described [18]. Samples containing equal amount of proteins
were separated on 10% SDS-polyacrylamide gels in a minigel
apparatus (Mini-PROTEAN II, Bio-Rad) and transferred to
nitrocellulose membranes. The membranes were blocked with
5% milk in TBS-T, and were incubated overnight at 4uCw i t h
anti-insulin receptor b, anti-PPAR-c, anti-PGC1a, anti-Glut4,
anti-AMPK, anti-phosphorylated AMPK (pAMPK, Thr172),
anti-ACC, anti-phosphorylated ACC (pACC, Ser79), anti-
LKB1, anti-phosphorylated LKB1 (pLKB1, Ser428), anti-
PP2AA, anti-PP2AB, anti-PP2Ca and anti-GAPDH (loading
control) antibodies. After washing blots to remove excessive
primary antibody binding, blots were incubated for 1 hr with
horseradish peroxidase (HRP)–conjugated secondary antibody
(1:5,000). Antibody binding was detected using enhanced
chemiluminescence (Amersham Pharmacia, Piscataway, NJ),
and film was scanned and the intensity of immunoblot bands
was detected with a Bio-Rad Calibrated Densitometer (Model:
GS-800).
Data Analysis
Data are Mean 6 SEM. Difference was calculated by repeated
measures analysis of variance (ANOVA) followed by a Tukey’s
post hoc analysis. A p value ,0.05 was considered significant.
Figure 2. Cardiomyocyte contractile properties from adult FVB and ADH mice with or without acute ethanol (EtOH) challenge (3 g/
kg, i.p. for 3 days). A: Resting cell length; B: Peak shortening (normalized to cell length); C: Maximal velocity of shortening (+ dL/dt); D: Maximal
velocity of relengthening (2 dL/dt); E: Time-to-PS (TPS); and F: Time-to-90% relengthening (TR90). Mean 6 SEM, n=80–81 cells from 3–4 mice per
group, * p,0.05 vs.FVB group, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g002
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General features and OGTT of FVB and ADH mice treated
with ethanol
Neither ethanol treatment nor ADH transgene altered body
and organ (heart, liver and kidney) weights or organ size
(manifested as the organ-to-body weight ratio). As expected,
acute ethanol exposure elicited comparable elevations in blood
alcohol level compared with the non-ethanol-treated mice.
While neither acute ethanol exposure nor ADH overtly affected
cardiac ATP levels, acute ethanol treatment significantly
elevated the AMP levels and AMP/ATP ratio in both mouse
groups with a more pronounced increase in AMP/ATP ratio in
the ADH mice. Plasma insulin levels and blood alcohol levels
were significantly elevated in a comparable manner in both
groups following acute ethanol challenge (Table 1). Following
the oral glucose challenge, serum glucose levels in all four mouse
groups began to drop after peaking at 15 min and returned
towards baseline values after 120 min. Ethanol-treated FVB and
ADH mice (FVB-EtOH and ADH-EtOH) both displayed
slightly elevated (although non-significant) serum glucose levels
between 30 and 90 min after glucose challenge compared with
WT mice. This is consistent with the significantly greater area
underneath the curve (AUC) in both ethanol-treated groups
with an exaggeration in ADH-EtOH mice (Fig. 1). These data
favor the existence of glucose intolerance following acute
ethanol challenge with an exacerbated glucose disposal defect
in ADH mice.
Mechanical and intracellular Ca
2+ properties of murine
cardiomyocytes in FVB and ADH mice
Neither ethanol nor ADH transgene overtly affected resting cell
length. However, cardiomyocytes from ethanol-treated FVB mice
displayed significantly reduced peak shorting (PS) and maximal
velocity of shortening/relengthening (6 dL/dt) associated with
prolonged time-to-90% relengthening (TR90) and normal time-to-
PS (TPS). Consistent with previous finding from chronic alcohol
administration study [15], ADH transgene accentuated the acute
ethanol challenge-induced cardiomyocyte mechanical dysfunc-
tions without eliciting any overt effect by itself (Fig. 2). To explore
the potential mechanism(s) of action involved in the ADH-elicited
augmentation of acute ethanol exposure-induced cardiomyocyte
mechanical defect, intracellular Ca
2+ homeostasis was evaluated
using the fluorescence dye fura-2. Our results indicated that acute
ethanol exposure significantly reduced electrically-stimulated rise
in intracellular Ca
2+ and prolonged intracellular Ca
2+ decay rate
(both single- and bi-exponential) without affecting basal intracel-
lular Ca
2+ levels, the effects of which were exacerbated by the
ADH transgene. Consistent with the cell shortening response,
Figure 3. Intracellular Ca
2+ transient properties in cardiomyocytes from adult FVB and ADH mice with or without acute ethanol
(EtOH) challenge (3 g/kg, i.p. for 3 days). A: Baseline fura-2 fluorescence intensity (FFI); B: Electrically-stimulated rise in FFI (DFFI); C: Single
exponential intracellular Ca
2+ decay rate; and D: Bi-exponential intracellular Ca
2+ decay rate. Mean 6 SEM, n=70 cells from 3–4 mice per group,
*p ,0.05 vs. FVB group, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g003
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2+ properties by
itself (Fig. 3).
Effect of increasing stimulation frequency on myocyte
shortening
Murine hearts normally contract at high frequencies, whereas
our mechanical recording was performed at 0.5 Hz. To evaluate
the impact of acute ethanol exposure and/or ADH transgene
overexpression on cardiac function under higher frequencies, we
increased the stimulus frequency up to 5.0 Hz (300 beats/min)
and recorded the steady-state peak shortening. Cardiomyocytes
were initially stimulated to contract at 0.5 Hz for 5 min to ensure
a steady-state before commencing the frequency response. Fig. 4
displays a negative staircase of peak shortening (PS) with
increased stimulus frequency in all 4 groups with a steeper
decline in PS in both ethanol-treated groups (although PS decline
in FVB-EtOH group failed to reach significant level between 1
and 5 Hz). The loss in PS value was more pronounced in
ethanol-treated ADH compared with FVB-EtOH group at all
frequencies with the exception of 1 Hz. These data favor a
possible role of reduced intracellular Ca
2+ cycling or stress
tolerance capacity under acute ethanol challenge, which may be
accentuated by ADH.
Effect of acute ethanol exposure on whole heart function
in FVB and ADH mice
To assess the impact ADH on myocardial contractile function
in the setting of whole heart following acute ethanol challenge, the
Langendroff perfused whole heart function was evaluated. Our
data shown in Fig. 5 revealed that acute ethanol challenge
resulted in a rapid decline in LVDP and 6 dP/dt in FVB mice
starting at 40 min of perfusion despite displaying normal baseline
contractility parameters similar to those in FVB group. Interest-
ingly, baseline LVDP and 6 dP/dt were significantly lower in
ADH mice treated with ethanol than FVB and FVB-EtOH
groups and remained low throughout the 90 min perfusion
duration. Overexpression of ADH transgene itself did not affect
the baseline as well as time-dependent change in LVDP and
6 dP/dt.
Effect of acute ethanol challenge on insulin receptor,
PPAR-c,P G C 1 a and Glut4 in FVB and ADH mice
To better understand the ADH-induced exacerbation of
the dampened glucose tolerance and myocardial contractile
function in response to acute ethanol challenge, protein
expression of insulin receptor, PPAR-c,P G C 1 a and Glut4
was examined in FVB and ADH mice with or without ethanol
challenge. Our data revealed that ethanol challenge downreg-
ulated insulin receptor b and upregulated PGC1a in a
Figure 4. Change in cardiomyocyte contraction in response to
increasing stimulus frequency (0.1–5.0 Hz) in adult FVB and
ADH mice with or without acute ethanol (EtOH) challenge (3 g/
kg, i.p. for 3 days). Peak shortening (PS) amplitude was normalized to
the PS value obtained at 0.1 Hz from the same cell. Mean 6 SEM,
n=24–26 cells from 3–4 mice per group, * p,0.05 vs.FVB group,
# p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g004
Figure 5. Langendorff myocardial contractile function from
adult FVB and ADH mice with or without acute ethanol (EtOH)
challenge (3 g/kg, i.p. for 3 days). Cardiac contractile function was
assessed using a perfusion system for 90 min. A: Left ventricular
developing pressure (LVDP); B and C: Maximal velocity of pressure
development (+dP/dt) and decline (2dP/dt). Mean 6 SEM, n=4 hearts
per group, * p,0.05 vs. FVB group, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g005
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effect from ADH transgene by itself. Consistent with the
OGTT data, acute ethanol treatment significantly downregu-
lated the insulin postreceptor signaling molecule PPAR-c
expression, the effect of which was exaggerated by ADH.
Neither acute ethanol challenge nor ADH transgene affected
expression of Glut4 (Fig. 6).
Effect of acute ethanol challenge on AMPK, ACC and
LKB1 in FVB and ADH mice
To explore if the AMPK signaling cascade was involved in
ADH and/or ethanol-induced cardiac contractile response,
AMPK, its downstream signaling molecule ACC and the
AMPK activating signal LKB1 were examined. Neither acute
ethanol treatment nor ADH affected the expression of AMPK
and ACC. However, phosphorylation of both AMPK and ACC
was increased by acute ethanol exposure (both absolute value
and phosphorylated-to-pan protein ratio), the effect of which
was accentuated by ADH. ADH transgene itself did not elicit
any effect on the phosphorylation of AMPK and ACC (Fig. 7).
We went on to examine the involvement of LKB1 in ADH and
ethanol-induced response in AMPK/ACC activation. Neither
ethanol nor ADH transgene affected the levels of pan LKB1. In
line with its effect on AMPK and ACC phosphorylation,
acute ethanol challenge enhanced the phosphorylation of
LKB1 (both absolute and pLKB1/LKB1 ratio), the effect of
which was augmented by ADH transgene. Last but not the
least, ADH transgene itself did not affect LKB1 phosphoryla-
tion (Fig. 8).
Effect of acute ethanol challenge on protein phosphatase
expression in FVB and ADH mice
To further explore the mechanism of action behind ADH and/
or ethanol-induced response in AMPK activation, expression of
protein phosphatase PP2A (both PP2AA and PP2AB) and PP2C
was examined in FVB and ADH myocardium with or without
acute ethanol challenge. Neither acute ethanol exposure nor ADH
affected the expression of PP2AB. Interestingly, expression of
PP2AA was significantly downregulated by acute ethanol expo-
sure, the effect of which was intensified by ADH. To the contrary,
expression of PP2Ca was upregulated by acute ethanol challenge,
the effect was unaffected by ADH transgene. In addition, ADH
transgene itself did not affect the expression of PP2AA and PP2Ca
(Fig. 9).
Figure 6. Expression of insulin receptor b (IR-b), PPAR-c, PGC1a and Glut4 in myocardium from FVB and ADH mice with or without
acute ethanol challenge (3 g/kg, i.p. for 3 days). A: IR-b; B: PPAR-c; C: PGC1a and D: Glut4. Insets: Representative gel blots depicting expression
of IR-b, PPAR-c, PGC1a, Glut4 and GAPDH (loading control). Mean 6 SEM, n=6–8 samples per group, * p,0.05 vs. FVB group, # p,0.05 vs. FVB-EtOH
group.
doi:10.1371/journal.pone.0011268.g006
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induced changes in cell shortening
To further examine the role of AMPK in ethanol-induced
cardiac contractile defects, freshly isolated cardiomyocytes from
wild-type FVB mice were treated with ethanol (240 mg/dl) for
2 hrs in the absence or presence of the AMPK inhibitor
compound C (10 mM) [19]. Our data shown in Fig. 10 indicated
that the short-term treatment of ethanol significantly decreased
PS and 6 dL/dt as well as prolonged TPS and TR90 without
affecting resting cell length. Interestingly, compound C signif-
icantly alleviated the acute ethanol exposure-induced mechan-
ical defects without eliciting any effects on cardiomyocyte
mechanics by itself. These data favor a likely role of AMPK
in the acute ethanol exposure-induced cardiac contractile
dysfunction.
Discussion
Alcoholic cardiomyopathy is featured by compromised myo-
cardial contractility [2,3,4,7]. This is coincided with our current
observation of reduced myocardial contraction in ethanol-
challenged murine hearts. Furthermore, data from our present
study revealed change in the AMP-to-ATP ratio and hyperacti-
vated AMPK signaling cascade following acute ethanol challenge,
which is associated with ethanol-elicited cardiac dysfunction,
intracellular Ca
2+ mishandling, glucose intolerance and hyperin-
Figure 7. Expression of pan and phosphorylated AMPK and ACC in myocardium from FVB and ADH mice with or without acute
ethanol challenge (3 g/kg, i.p. for 3 days). A: pan AMPK; B: pan ACC; C: phosphorylated AMPK (pAMPK); D: phosphorylated ACC (pACC);
E: pAMPK/AMPK ratio and F: pACC/ACC ratio. Insets: Representative gel blots depicting expression of pan and phosphorylated AMPK and ACC.
Mean 6 SEM, n=5–7 samples per group, * p,0.05 vs. FVB group, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g007
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first time that the cellular fuel AMPK signaling cascade following
ethanol exposure may be augmented by ADH. These observations
are in favor of the notion that facilitated ethanol metabolism via
ADH enzyme exacerbates acute ethanol toxicity-induced myo-
cardial dysfunction and glucose intolerance possibly related to
over-stimulation of the cellular fuel AMPK.
Results from our study revealed that ADH accentuated ethanol-
induced cardiac contractile and intracellular Ca
2+ anomalies. This
is supported by results from our current study in that ADH elicited
a more pronounced deterioration in the heart contractile function,
as evidenced by reduced 6 dP/dt and LVDP, depressed peak
shortening and 6 dL/dt associated with prolonged TR90 following
ethanol challenge Moreover, ADH deteriorated ethanol-induced
decrease in electrically-stimulated rise in intracellular Ca
2+,
prolongation of intracellular Ca
2+ decay rate and loss of
intracellular Ca
2+ cycling/handling capacity (the steeper staircase
in peak shortening change in response to increased stimulus
frequency). These data are in agreement with our earlier
observations following alcohol intake using similar transgenic
murine model [13,15]. More interestingly, the ADH and/or acute
ethanol-induced cardiac contractile and intracellular Ca
2+ re-
sponses were coordinated with hyperactivated AMPK signaling
cascade including phosphorylation of AMPK, ACC and LKB1 as
well as downregulation of protein phosphatase PP2A subunit and
PPAR-c. The serine/threonine protein kinase AMPK is a cellular
energy sensor for glucose and lipid metabolism regulating the
cellular energy balance. The heterotrimeric AMPK enzyme is
widely expressed in adipose tissue, skeletal muscle, liver, heart,
pancreas and brain [20,21]. Physiological stimuli such as ischemia
reperfusion, hormones and nutrients may activate AMPK by
elevating intracellular AMP/ATP ratio. Data from our current
study revealed an elevation in cardiac AMP-to-ATP ratio
following acute ethanol challenge with a further raise in the
ADH ethanol-treated mice. Typically, elevation of intracellular
AMP or the AMP-to-ATP ratio serves as the main activator of
AMPK through several mechanisms. AMP itself is known to
directly turn on AMPK. Second, AMP activates the AMPK
upstream kinase LKB1 to phosphorylate a-subunit of AMPK at
Thr172. Last, the binding of AMP to AMPK renders it a better
substrate for LKB1 and reduces its substrate affinity for protein
phosphatase [22,23,24]. The AMPK upstream kinase LKB1
kinase monitors the levels of glucose and the AMP/ATP ratio,
governing the Thr172 phosphorylation of the a catalytic subunit of
AMPK [22,25]. Result from our current study revealed that acute
ethanol treatment turned on LKB1 phosphorylation with a further
increase in ADH mice, supporting a likely role of LKB1 in the
ADH and ethanol-induced AMPK activation (shown by phos-
phorylation of AMPK and ACC). AMPK activation limits
biosynthetic pathways while facilitating catabolic pathways to
conserve energy by ATP generation through enhancing oxidative
metabolism and mitochondrial biogenesis [26,27]. This is
somewhat supported by our current data of upregulated PGC-
1a expression in response to acute ethanol exposure although such
effect was unaffected by ADH overexpression. Although data from
our present study fail to provide any precise mechanism of action
Figure 8. Expression of pan and phosphorylated LKB1 in myocardium from FVB and ADH mice with or without acute ethanol
challenge (3 g/kg, i.p. for 3 days). A: Representative gel blots depicting expression of LKB1, phosphorylated LKB1 (pLKB) and GAPDH (loading
control); B: pan LKB1; C: pLKB1; and D: pLKB1/LKB1 ratio. Mean 6 SEM, n=6–8 samples per group, * p,0.05 vs. FVB group, # p,0.05 vs. FVB-EtOH
group.
doi:10.1371/journal.pone.0011268.g008
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accumulation of reactive oxygen species in response to ethanol
exposure is believed to play an important role. Ethanol or
acetaldehyde has been shown to trigger oxidative stress and
apoptosis via activation of stress signaling such as c-Jun phosphor-
ylation [1–3]. This is supported by our recent findings of elevated
O2
2 anion production and apoptosis in murine hearts following
ethanol challenge, the effect of which was accentuated by the ADH
transgene [13]. Evidence from our group also revealed that ADH
produced greater levels of lipid peroxidation and protein carbonyls
in hearts from the alcohol-fed mice [4], consolidating an likely role
of free radical formation in AMPK activation [28] following acute
ethanol exposure. Ethanol has been shown to elicit a number of
pathophysiological responses including compromised glucose
transport and gastric acid secretion via an AMPK-dependent
manner [29,30], similar to our current finding. Consistently,
AMPK activity was found elevated within a few hours after ethanol
exposure in liver and skeletal cells [31,32]. This is also supported by
our observation that the AMPK inhibitor compound C effectively
alleviated acute ethanol exposure-induced cardiomyocyte dysfunc-
tion. Nonetheless, recent finding from Crabb and colleagues
suggested that ethanol is capable of inhibiting (rather than
activating) hydrogen peroxide-induced AMPK activation in
hepatoma cells [23], suggesting a likely paradoxical role of AMPK
in ethanol-elicited effects. It is possible that difference in tissue type
and experimental setting (in vivo treatment versus cell culture) may
contribute to the discrepant effect of ethanol on AMPK activation
between our study and the previous report [23].
Observation from our study also depicted downregulation of PP2A
(PP2AA in particular without change in PP2AB) following acute
ethanol challenge, the effect of which was augmented by the ADH
transgene. To the contrary, acute ethanol exposure elicited a
comparable upregulation of PP2Ca in both FVB and ADH mice.
PP2A and PP2Ca, two protein phosphotases, are known to
dephosphorylate and inactivate AMPK [23]. AMP was reported to
increase AMPK activation by directly inhibiting phosphatase or
indirectly making AMPK a poor substrate for phosphatases [33].
Therefore, ADH and ethanol-induced effect on protein phosphatases
(especially PP2A) may play a role in hyperactivated AMPK signaling in
our current experimental setting. Our findings suggest that the
phosphorylation of AMPK at Thr172 may be influenced by the
expression of PP2A but less likely PP2Cain ethanol-treated ADH mice.
AMPK plays an essential role for the maintenance of
myocardial function [34]. Interrupted AMPK signaling integrity
may contribute to the onset and development of neurodegener-
ative disorders, diabetes and ischemia reperfusion-induced heart
damage [34]. Recently, AMPK signaling defect also received some
attentions in alcoholic complications since ethanol metabolism
directly affects energy metabolism such as reduced ATP level and
mitochondrial respiratory rates [11]. This is consistent with our
current finding of elevated phosphorylation of AMPKa, ACC and
LKB1 associated with enhanced AMP-to-ATP ratio in hearts
following acute ethanol exposure. More intriguingly, the ethanol-
induced changes in AMPK, ACC, LKB1 and the AMP/ATP ratio
were exaggerated by ADH, consolidating the contribution of
ethanol metabolism to energy metabolism. These observations
were in line with the changes in myocardial contractility and oral
glucose tolerance in FVB and ADH mice following ethanol
exposure, suggesting a likely role of AMPK in ADH-induced
exacerbation of myocardial injury in response to ethanol exposure.
Figure 9. Expression of protein phosphatases in myocardium from FVB and ADH mice with or without acute ethanol challenge (3 g/
kg, i.p. for 3 days). A: Representative gel blots depicting expression of PP2AA, PP2AB, PP2Ca and GAPDH (loading control); B: PP2AA; C: PP2AB; and
D: PP2Ca. Mean 6 SEM, n=6–8 samples per group, * p,0.05 vs. FVB group, # p,0.05 vs. FVB-EtOH group.
doi:10.1371/journal.pone.0011268.g009
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including ischemia and reperfusion injury, diabetic and alcoholic
cardiomyopathy [22,34]. Insulin also regulates various aspects of
cardiovascular metabolism and function including glucose and
long-chain fatty acid metabolism, protein translation and vascular
tone [35]. As mentioned earlier, AMPK signaling pathway is
involved in insulin signaling in the heart [36,37]. In our study, the
over-phosphorylated AMPK signaling following facilitated ethanol
metabolism (ADH) may contribute to dampened insulin signaling
following ethanol challenge at a checkpoint underneath the insulin
receptor. Our observation of equally down-regulated insulin
receptor in the ethanol-treated FVB and ADH mice does not
favor a major role of insulin receptor in the ADH-accentuated
myocardial mechanical defects. The fact that ADH augmented
acute ethanol exposure-induced downregulation in PPAR-c
substantiated the critical role of post-insulin receptor signaling in
the ethanol-induced cardiac contractile defect and intracellular
Ca
2+ mishandling. PPAR-c has been shown to play a critical role
in cardiac contractile function. PGC-1a, a member of a family of
transcription coactivators, is essential for mitochondrial biogenesis
and participates in the regulation of both carbohydrate and lipid
metabolism [38]. Our finding of comparable upregulation in the
Figure 10. Effect of the AMPK inhibitor compound C on ethanol-induced cardiomyocyte contractile defects. Freshly isolated
cardiomyocytes from FVB mice were incubated with ethanol (240 mg/dl) in the presence or absence of compound C (10 mM) for 2 hrs. A: Resting cell
length; B: Peak shortening (normalizedtoresting cell length); C: Maximal velocity of shortening (+ dL/dt); D: Maximal velocity of relengthening(2 dL/dt);
E: Time-to-peak shortening (TPS) and F: Time-to-90% relengthening (TR90). Mean 6 SEM, n=59–77 cells from 3 mice per group, * p,0.05 vs. control
group, # p,0.05 vs. ethanol (EtOH) group.
doi:10.1371/journal.pone.0011268.g010
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favor an involvement of mitochondrial biogenesis and Gut4 in
the ADH-exacerbated myocardial defect following acute ethanol
challenge. Although long-term ethanol exposure is known to
inhibit Glut4 expression via an AMPK-dependent pathway in
adipocytes [29], our current data were unable to address the
intimate interplay among AMPK signaling, insulin sensitivity,
myocardial and intracellular Ca
2+ derangement following acute
ethanol exposure.
In summary, the present study has provided convincing
evidence that cardiac overexpression of ADH exacerbated acute
ethanol exposure-induced myocardial contractile and intracellular
Ca
2+ dysregulation associated with altered insulin sensitivity and
hyperphosphorylated AMPK signaling. These data support a
possible role of ethanol metabolism and AMPK signaling cascade
in acute ethanol toxicity-elicited alcoholic myopathic alteration.
These data should shed some lights towards a better understand-
ing of the role of cardiac energy metabolism, AMPK and insulin
signaling in alcoholic myocardial dysfunction. On the other hand,
pharmacological inhibition of ADH enzyme has been shown to
diminish or prevent ethanol-induced undesirable effects such as
lactacidemia and hypoglycemia [39], indicating the therapeutic
potential of this crucial ethanol oxidation enzyme. Further
investigation is warranted to better elucidate the therapeutic value
of AMPK cascade in the clinical management of binge drinking-
associated myopathic anomalies.
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